EDMONTON, Alberta (AP) — EDMONTON, Alberta (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Tuesday reported third-quarter earnings of $31.6 million.
On a per-share basis, the Edmonton, Alberta-based company said it had profit of 23 cents.
The biotechnology company posted revenue of $73.5 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $68.5 million.
Aurinia expects full-year revenue in the range of $275 million to $280 million.
Aurinia shares have increased 47% since the beginning of the year. The stock has increased 80% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
